Legacy Financial Advisors, Inc. Novo Nordisk A S Transaction History

Legacy Financial Advisors, Inc.

$515 Million
Q3 2024

A detailed history of Legacy Financial Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 13,556 shares of NVO stock, worth $1.42 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

13,556

Previous 13,492 0.47%

Holding current value

$1.42 Million

Previous $1.93 Million 16.16%

% of portfolio

0.31%

Previous 0.38%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $7,620 - $9,306	64 Added 0.47%	13,556 $1.61 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $94,732 - $113,414	772 Added 6.07%	13,492 $1.93 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $70,966 - $94,464	695 Added 5.78%	12,720 $1.63 Million
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $122,277 - $146,891	1,393 Added 13.1%	12,025 $1.24 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $531,453 - $1.17 Million	5,844 Added 122.06%	10,632 $966,000
Q2 2023 Aug 08, 2023	SELL	$155.98 - $172.65 $41,802 - $46,270	-268 Reduced 5.3%	4,788 $774,000
Q1 2023 May 03, 2023	BUY	$132.34 - $159.14 $83,903 - $100,894	634 Added 14.34%	5,056 $804,000
Q4 2022 Feb 06, 2023	BUY	$102.55 - $135.33 $7,178 - $9,473	70 Added 1.61%	4,422 $598,000
Q3 2022 Nov 09, 2022	BUY	$95.28 - $116.93 $50,688 - $62,206	532 Added 13.93%	4,352 $434,000
Q2 2022 Aug 08, 2022	BUY	$103.24 - $121.81 $32,933 - $38,857	319 Added 9.11%	3,820 $426,000
Q1 2022 May 04, 2022	BUY	$93.1 - $112.54 $10,613 - $12,829	114 Added 3.37%	3,501 $389,000
Q4 2021 Feb 04, 2022	BUY	$95.88 - $117.08 $37,584 - $45,895	392 Added 13.09%	3,387 $379,000
Q3 2021 Oct 26, 2021	BUY	$84.42 - $106.62 $50,905 - $64,291	603 Added 25.21%	2,995 $288,000
Q2 2021 Jul 21, 2021	BUY	$67.66 - $84.76 $161,842 - $202,745	2,392 New	2,392 $200,000
Q2 2019 Aug 07, 2019	SELL	$46.79 - $52.47 $130,076 - $145,866	-2,780 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $53,360 - $60,577	-1,151 Reduced 29.28%	2,780 $145,000
Q4 2018 Jan 16, 2019	BUY	$41.54 - $47.25 $1,869 - $2,126	45 Added 1.16%	3,931 $181,000
Q3 2018 Oct 30, 2018	BUY	$46.76 - $51.24 $152,764 - $167,401	3,267 Added 527.79%	3,886 $183,000
Q2 2018 Jul 17, 2018	SELL	$44.29 - $50.42 $3,853 - $4,386	-87 Reduced 12.32%	619 $31,000
Q1 2018 Apr 12, 2018	SELL	$48.49 - $58.14 $11,928 - $14,302	-246 Reduced 25.84%	706 $35,000
Q4 2017 Feb 09, 2018	BUY	$47.53 - $53.73 $45,248 - $51,150	952	952 $51,000

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.

Account

Legacy Financial Advisors, Inc. Novo Nordisk A S Transaction History